You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 075845


✉ Email this page to a colleague

« Back to Dashboard


NDA 075845 describes OXAPROZIN, which is a drug marketed by Abraxeolus, Actavis Elizabeth, Amneal Pharms Co, Beximco Pharms Usa, Chartwell, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan Pharms Inc, Norvium Bioscience, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the OXAPROZIN profile page.

The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
Summary for 075845
Tradename:OXAPROZIN
Applicant:Abraxeolus
Ingredient:oxaprozin
Patents:0
Pharmacology for NDA: 075845
Mechanism of ActionCyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 075845
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAPROZIN oxaprozin TABLET;ORAL 075845 ANDA Eon Labs, Inc. 0185-0141 0185-0141-01 100 TABLET in 1 BOTTLE (0185-0141-01)
OXAPROZIN oxaprozin TABLET;ORAL 075845 ANDA St. Mary's Medical Park Pharmacy 60760-203 60760-203-14 14 TABLET in 1 BOTTLE, PLASTIC (60760-203-14)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Jan 31, 2001TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.